|
|
.
See Category: Diseases of the genitourinary system
ICD-10 (CM) Code and Descriptor
|
N05.2 |
Unspecified nephritic syndrome with diffuse membranous glomerulonephritis
|
N052 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 36.45%
|
18.24%
|
11.38%
|
9.79%
|
6.64%
|
3.31%
|
2.79%
|
2.21%
|
1.00%
|
1.00%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N05.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
82570
|
ASSAY OF URINE CREATININE |
724
|
755
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
703
|
707
|
|
84156
|
ASSAY OF PROTEIN URINE |
691
|
691
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
453
|
453
|
|
80053
|
COMPREHEN METABOLIC PANEL |
370
|
370
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
341
|
342
|
|
80069
|
RENAL FUNCTION PANEL |
297
|
297
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
291
|
293
|
|
82043
|
UR ALBUMIN QUANTITATIVE |
201
|
201
|
|
96413
|
CHEMO IV INFUSION 1 HR |
200
|
200
|
|
85027
|
COMPLETE CBC AUTOMATED |
200
|
201
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
183
|
539
|
|
83970
|
ASSAY OF PARATHORMONE |
169
|
170
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
165
|
262
|
|
84100
|
ASSAY OF PHOSPHORUS |
162
|
162
|
|
83735
|
ASSAY OF MAGNESIUM |
152
|
152
|
|
80048
|
METABOLIC PANEL TOTAL CA |
152
|
152
|
|
J2930
|
METHYLPREDNISOLONE INJECTION |
142
|
494
|
|
J9312
|
INJ., RITUXIMAB, 10 MG |
138
|
11,190
|
|
86255
|
FLUORESCENT ANTIBODY SCREEN |
125
|
125
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N05.2 related to the following DRG Codes:
698-700
|
